JULIE HERRINGTON: Open Payments
NPI 1346723863 · CARTHAGE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 27 payments from 11 companies in 2025. Trend: 2023 $470 · 2024 $397 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| ABBVIE INC. | 5 | $77 |
| ANI Pharmaceuticals, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Verona Pharma, Inc. | 2 | $33 |
| Averitas Pharma Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: BREZTRI, FARXIGA, VRAYLAR, PURIFIED CORTROPHIN GEL, Ozempic, AIRSUPRA, CAPLYTA, Ohtuvayre.
Industry payments across MS — which companies pay providers there.
